Mary Lanning Healthcare Morrison Cancer Center — Hastings, Nebraska

Mary Lanning Healthcare Morrison Cancer Center is a clinical research site located in Hastings, Nebraska, United States 68901.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Mary Lanning Healthcare Morrison Cancer Center has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia (CLL), Triple Negative Breast Cancer, Pancreatic Cancer.

Sponsors: Pharmacyclics LLC., Gilead Sciences, University of Nebraska.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Hastings

Browse all research sites in Nebraska · View every site in Hastings

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mary Lanning Healthcare Morrison Cancer Center?

Mary Lanning Healthcare Morrison Cancer Center has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mary Lanning Healthcare Morrison Cancer Center conducted?

Mary Lanning Healthcare Morrison Cancer Center has 4 clinical trials on record, with 2 currently active. Their work covers Chronic Lymphocytic Leukemia (CLL), Triple Negative Breast Cancer, Pancreatic Cancer.

Is Mary Lanning Healthcare Morrison Cancer Center accredited by Crixeo Clinical Trials?

Mary Lanning Healthcare Morrison Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mary Lanning Healthcare Morrison Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.